CDK9 and mantle cell lymphoma: Since the combination of venetoclax plus CDK9 inhibition induced greater apoptosis relative to either as monotherapy in the seven MCL cases, which have distinct cytogenetic backgrounds, it would be interesting to test their efficacy in MCL samples harboring SWI‐SNF mutations.